Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease.
Jimd Reports
Goker-Alpan, Ozlem O; Gambello, Michael J MJ; Maegawa, Gustavo H B GH; Nedd, Khan J KJ; Gruskin, Daniel J DJ; Blankstein, Larry L; Weinreb, Neal J NJ